US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 3.090
  • +0.020+0.65%
Close Dec 20 16:00 ET
  • 3.050
  • -0.040-1.29%
Post 20:01 ET
322.56MMarket Cap-1.61P/E (TTM)

About Revance Therapeutics Company

Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Nashville, TN.

Company Profile

SymbolRVNC
Company NameRevance Therapeutics
Listing DateFeb 6, 2014
Issue Price16.00
Founded1999
CEOMr. Mark J. Foley
MarketNASDAQ
Employees597
Fiscal Year Ends12-31
Address1222 Demonbreun Street,Suite 2000
CityNashville
ProvinceTennessee
CountryUnited States of America
Zip Code37203
Phone1-615-724-7755
Websitehttp://www.revance.com

Company Executives

  • Name
  • Position
  • Salary
  • Mark J. Foley
  • Director and Chief Executive Officer
  • 10.07M
  • Erica Jordan
  • Chief Commercial Officer
  • --
  • Dr. David A. Hollander, M.D.
  • Chief Medical Officer and Global Therapeutics Franchise Lead
  • --
  • Tobin C. Schilke
  • Chief Financial Officer and Principal Accounting Officer
  • 3.97M
  • Dwight Moxie
  • Chief Legal Officer
  • 3.53M
  • Angus Charles Russell
  • Chairman of the Board
  • 346.03K
  • Olivia C. Ware, M.B.A.
  • Independent Director
  • 295.03K
  • Carey O’Connor Kolaja
  • Independent Director
  • 304.18K
  • Julian S. Gangolli
  • Independent Director
  • 305.03K
  • Jill Beraud
  • Independent Director
  • 317.53K
  • Christian W. Nolet, C.P.A.
  • Independent Director
  • 315.03K
  • Dr. Vlad Coric, M.D.
  • Independent Director
  • 421.49K
Heat List
US
Overall
Symbol
Price
% Chg

No Data